CAREX
Price
$21.41
Change
+$0.22 (+1.04%)
Updated
Jun 22 closing price
Net Assets
54.42M
RSLDX
Price
$86.67
Change
+$0.73 (+0.85%)
Updated
Jun 22 closing price
Net Assets
91.47B
Interact to see
Advertisement

CAREX vs RSLDX

CAREX vs RSLDX Comparison Chart in %
View a ticker or compare two or three
VS
CAREX vs. RSLDX commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAREX is a StrongBuy and RSLDX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLDX has more cash in the bank: 91.5B vs. CAREX (54.4M). RSLDX pays higher dividends than CAREX: RSLDX (0.81) vs CAREX (0.00). CAREX was incepted earlier than RSLDX: CAREX (6 years) vs RSLDX (11 years). CAREX (2.05) is less costly to investors than RSLDX (0.80). CAREX is a more actively managed with annual turnover of: 64.00 vs. RSLDX (41.00). RSLDX has a lower initial minimum investment than CAREX: RSLDX (250) vs CAREX (2500). CAREX annual gain was more profitable for investors over the last year : 32.81 vs. RSLDX (24.17). CAREX return over 5 years is better than : 14.71 vs. RSLDX (0.10).
CAREXRSLDXCAREX / RSLDX
Total Expense Ratio1.300.80163%
Annual Report Gross Expense Ratio2.050.80256%
Fund Existence6 years11 years-
Gain YTD18.01616.964106%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets54.4M91.5B0%
Annual Yield % from dividends0.000.81-
Returns for 1 year32.8124.17136%
Returns for 3 years60.2343.85137%
Returns for 5 years14.710.1014,812%
Returns for 10 years194.46109.06178%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NMPAX16.360.03
+0.16%
Columbia Mid Cap Index Inst
GSISX36.39N/A
N/A
Goldman Sachs International Eq ESG Svc
IJSSX16.63N/A
N/A
VY® JPMorgan Small Cap Core Equity S
EXEYX14.37N/A
N/A
Manning & Napier Equity Series S
MLACX2.88-0.02
-0.69%
NYLI Winslow Large Cap Growth Class C